157
Views
3
CrossRef citations to date
0
Altmetric
Articles

Genetic predisposition to elevated levels of C-reactive protein is associated with a decreased risk for preeclampsia

, , , , , , , , , , & show all
Pages 30-35 | Received 29 Feb 2016, Accepted 08 Aug 2016, Published online: 22 Sep 2016

References

  • Solomon CG, Seely EW. Preeclampsia – searching for the cause. N Engl J Med 2004;350(7):641–642.
  • Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001;357(9249):53–56.
  • Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatology 2009;33(3):130–137.
  • Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine (New York, NY). 1999;222(3):222–235.
  • Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatology 2012;36(1):56–59.
  • Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ (Clinical research ed). 2007;335(7627):974.
  • Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ (Clinical research ed). 2003;326(7394):845.
  • Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstetrics Gynecology 1999; 180 (2 Pt 1): 499–506.
  • Spracklen CN, Saftlas AF, Triche EW, et al. Genetic predisposition to dyslipidemia and risk of preeclampsia. Am J Hypertens 2015;28(7):915–923.
  • Smith CJ, Saftlas AF, Spracklen CN, et al. Genetic risk score for essential hypertension and risk of preeclampsia. Am J Hypertens 2016; 29(1):17–24.
  • Buurma AJ, Turner RJ, Driessen JH, et al. Genetic variants in pre-eclampsia: a meta-analysis. Human reproduction update. 2013; 19(3): 289–303.
  • Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Internal Med 2002;252(4):283–294.
  • Du Clos TW, Mold C. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunologic Res 2004;30(3):261–277.
  • Rebelo F, Schlussel MM, Vaz JS, et al. C-reactive protein and later preeclampsia: systematic review and meta-analysis taking into account the weight status. J Hypertens 2013;31(1):16–26.
  • Kashanian M, Aghbali F, Mahali N. Evaluation of the diagnostic value of the first-trimester maternal serum high-sensitivity C-reactive protein level for prediction of pre-eclampsia. J Obstetrics Gynaecology Res 2013;39(12):1549–1554.
  • Best LG, Saxena R, Anderson CM, et al. Two variants of the C-reactive protein gene are associated with risk of pre-eclampsia in an American Indian population. PloS one 2013;8(8):e71231.
  • Ahmed SK, Mahmood N, Malalla ZH, et al. C-reactive protein gene variants associated with recurrent pregnancy loss independent of CRP serum levels: A case-control study. Gene 2015;569(1):136–140.
  • Spracklen CN, Ryckman KK, Harland K, et al. Effects of smoking and preeclampsia on birth weight for gestational age. J Maternal-fetal Neonatal Med 2015;28(6):679–684.
  • Saftlas AF, Rubenstein L, Prater K, et al. Cumulative exposure to paternal seminal fluid prior to conception and subsequent risk of preeclampsia. J Reprod Immunol 2014;101-102( Journal Article):104–110.
  • Triche EW, Harland KK, Field EH, et al. Maternal-fetal HLA sharing and preeclampsia: variation in effects by seminal fluid exposure in a case-control study of nulliparous women in Iowa. J Reprod Immunol 2014;101-102( Journal Article):111–9.
  • Zhao L, Triche EW, Walsh KM, et al. Genome-wide association study identifies a maternal copy-number deletion in PSG11 enriched among preeclampsia patients. BMC Pregnancy Childbirth 2012;12:61.
  • Gifford RW, August PA, Cunningham G, et al. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstetrics Gynecology 2000;183(1):S1–S22.
  • Dehghan A, Dupuis J, Barbalic M, et al. Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 2011;123(7):731–738.
  • Qi Q, Forman JP, Jensen MK, et al. Genetic predisposition to high blood pressure associates with cardiovascular complications among patients with type 2 diabetes: two independent studies. Diabetes 2012;61(11):3026–3032.
  • Qi Q, Liang L, Doria A, et al. Genetic predisposition to dyslipidemia and type 2 diabetes risk in two prospective cohorts. Diabetes 2012;61(3):745–752.
  • Cornelis MC, Qi L, Zhang C, et al. Joint effects of common genetic variants on the risk for type 2 diabetes in U.S. men and women of European ancestry. Ann Internal Med 2009;150(8):541–550.
  • Keating BJ, Tischfield S, Murray SS, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PloS one 2008;3(10):e3583.
  • Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature 2010;467(7311):52–58.
  • Musunuru K, Lettre G, Young T, et al. Candidate gene association resource (CARe): design, methods, and proof of concept. Circulation Cardiovasc Genet 2010;3(3):267–275.
  • Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006;11(5):309–316.
  • Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM Monthly J Assoc Physicians 2003;96(11):793–807.
  • Udenze I, Amadi C, Awolola N, et al. The role of cytokines as inflammatory mediators in preeclampsia. Pan Afr Med J 2015;20:219.
  • Cemgil Arikan D, Aral M, Coskun A, et al. Plasma IL-4, IL-8, IL-12, interferon-gamma and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight. J Maternal-fetal Neonatal Med 2012;25(9):1569–1573.
  • Tousoulis D, Oikonomou E, Economou EK, et al. Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J 2016;37(22):1723–1732.
  • Fontes JD, Yamamoto JF, Larson MG, et al. Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. Atherosclerosis 2013;228(1):217–223.
  • Maric-Bilkan C, Symonds M, Ozanne S, et al. Impact of maternal obesity and diabetes on long-term health of the offspring. Exp Diabetes Res 2011;2011:163438.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.